INmune Bio Inc. Common stock Share Price
NASDAQ: INMB | Micro CapINmune Bio Inc. Common stock Stock Performance
Open $1.96 | Prev. Close $1.91 | Circuit Range N/A |
Day Range $1.95 - $2.10 | Year Range $1.10 - $2.85 | Volume 54,744 |
Average Traded $2.05 |
INmune Bio Inc. Common stock Share Price Today
As of 10 August 2026, INmune Bio Inc. Common stock's share price is $2.08. The stock opened at $1.96, compared to its previous close of $1.91. During today's trading session, INmune Bio Inc. Common stock's share price traded between $1.95 and $2.10, with an average price of $2.03. Over the past 52 weeks, the stock has recorded a high of $2.85 and a low of $1.10. In terms of performance, INmune Bio Inc. Common stock's share price has risen by 60.00% over the last six months and is up 2.21% on a year-on-year basis.
INmune Bio Inc. Common stock Share Price Chart
INmune Bio Inc. Common stock Stock Fundamentals & Key Indicators
Market Cap $51.50M | PE Ratio (TTM) -1.12 | Dividend Yield N/A |
EPS (TTM) $-1.86 | Revenue (TTM) $50000.00 | Return On Equity (TTM) -195.26% |
Profit Margin -91866.00% | Debt to Equity 0.36 | Quarterly Earnings Growth YoY N/A |
INmune Bio Inc. Common stock Quarterly Profit & Loss
All figures in USD
INmune Bio Inc. Common stock Annual Profit & Loss
All figures in USD
About INmune Bio Inc. Common stock
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.
INmune Bio Inc. Common stock Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.80 | $2.08 | +18.18% |
Jul 2026 | $1.64 | $1.76 | +7.98% |
Jun 2026 | $1.38 | $1.63 | +15.60% |
May 2026 | $1.44 | $1.41 | -1.40% |
Apr 2026 | $1.19 | $1.43 | +26.55% |
Mar 2026 | $1.27 | $1.13 | -13.08% |
Feb 2026 | $1.53 | $1.30 | -18.24% |
Jan 2026 | $1.58 | $1.59 | +2.25% |
Dec 2025 | $1.67 | $1.55 | -10.63% |
Nov 2025 | $1.85 | $1.74 | -4.92% |
Oct 2025 | $2.15 | $1.83 | -11.38% |
Sep 2025 | $2.02 | $2.06 | +1.47% |
INMB Share Price FAQs
What is INmune Bio Inc. Common stock share price today?
What is the 52 week high and 52 week low of INmune Bio Inc. Common stock stock?
What is INMB's market capitalisation today?
What is INMB's net income for the last quarter?
What is the 5 year returns of INMB?
What is the high & low stock price of INMB today?
Can I buy INMB shares in India?